3 unstoppable ASX shares to buy and hold for the next decade

These shares are going places over the remainder of the decade and beyond.

| More on:
A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

When it comes to building long-term wealth in the share market, few strategies are as powerful as identifying quality ASX shares and simply holding them for the long haul.

While markets rise and fall, great companies tend to keep growing over time — rewarding patient investors handsomely.

With that in mind, here are three unstoppable ASX shares that could have the potential to deliver outstanding returns over the next decade.

Goodman Group (ASX: GMG)

The first ASX share to buy and hold could be Goodman. It is a global leader in industrial property, developing and managing logistics warehouses, data centres, and last-mile distribution facilities.

Goodman has made a name for itself by partnering with some of the biggest names in e-commerce and cloud computing, including Amazon and Microsoft. As demand for logistics and digital infrastructure continues to rise, Goodman's development pipeline and global footprint put it in an enviable position.

It is also betting big on data centres, which are in demand due to the cloud computing and artificial intelligence megatrends. Overall, it is riding powerful secular tailwinds that make it a long-term standout.

Pro Medicus Ltd (ASX: PME)

Another unstoppable ASX share that could be a buy is Pro Medicus. It has quietly become one of Australia's most successful tech exports. The company develops high-performance medical imaging software used by some of the world's top hospitals and research institutions.

Its flagship product, Visage, helps radiologists read images faster and more accurately, and demand continues to grow as healthcare systems modernise. Importantly, Pro Medicus operates on a highly scalable, software-as-a-service (SaaS) model with exceptional profit margins.

With a robust sales pipeline, long-term partnerships, and the increasing importance of AI-driven diagnostics, Pro Medicus is in a sweet spot to continue compounding its earnings well into the future.

Xero Ltd (ASX: XRO)

Finally, Xero could be an ASX share to buy for the long term. It has transformed from a New Zealand startup into a global leader in cloud accounting software. Its intuitive platform is used by 4.4 million small businesses and accountants across the globe.

What makes Xero so compelling is the sticky nature of its business. Once a small business is integrated into Xero's ecosystem, they are unlikely to leave. That recurring revenue model, combined with ongoing international expansion, especially in the US and UK, positions Xero for sustained growth in a market estimated to be 100 million small to medium sized businesses.

Over the next decade, as more businesses move away from legacy software and embrace digital solutions, Xero stands to be one of the biggest beneficiaries.

John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Motley Fool contributor James Mickleboro has positions in Goodman Group, Pro Medicus, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Amazon, Goodman Group, Microsoft, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus and has recommended the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool Australia has recommended Amazon, Goodman Group, Microsoft, and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Group of children dressed in green hold up a globe relating to climate change.
Growth Shares

3 ASX 200 shares quietly riding major global trends

Analysts think these buy-rated shares are destined to have bright futures.

Read more »

Three excited business people cheer around a laptop in the office
Growth Shares

These amazing ASX shares could be compounding machines

Let's see why these quality shares could be key to generating big returns over the next decade.

Read more »

Hand holding Australian dollar (AUD) bills, symbolising ex dividend day. Passive income.
Growth Shares

Where to invest $5,000 in ASX shares for growth

These shares could be top picks for investors looking for growth opportunities.

Read more »

A happy young woman in a red t-shirt hold up two delicious burritos.
Growth Shares

I think these 2 exciting ASX growth shares are buys today

These compelling investments have a great outlook.

Read more »

Happy man working on his laptop.
Growth Shares

EOFY 2025: 3 ASX 200 shares to buy for the year ahead

Looking for quality picks for the next financial year? Here are three quality picks that analysts rate as buys.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Growth Shares

Macquarie tips nearly 50% upside for this ASX 200 stock

Let's see which stock the broker is feeling bullish about this week.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Growth Shares

3 excellent ASX 200 growth shares brokers rate as buys

Let's see why they think investors should be snapping them up right now.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Growth Shares

Why I think these 2 ASX shares are ideal for growth investors

These investments are very compelling.

Read more »